Jennifer Hoang, DO
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hoang’s office at (408) 885-5000 to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,811
Medicare paid this office $1,811 for 37 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 71 · Women 51% · Health risk score 1.54. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 70% · Diabetes 43%.
The office billed $22,483, Medicare allowed $2,195 and paid $1,811; for 45 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 37 | 45 | 71 | 1.54 | $22,483 | $1,811 |
| 2023 | 16 | 16 | 71 | 0.73 | $9,140 | $1,030 |
| 2022 | 28 | 32 | 70 | 0.97 | $16,978 | $2,024 |
| 2021 | 20 | 25 | 69 | 0.99 | $9,797 | $867 |
| 2019 | 127 | 267 | 74 | 2.37 | $116,429 | $18,657 |
| 2018 | 258 | 675 | 75 | 2.52 | $236,150 | $60,735 |
| 2017 | 101 | 275 | 71 | 2.72 | $75,213 | $21,577 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| Screening mammography | 13 | $1,723 | $133 |
2019: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $7,611 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,075 | $181 |
| Hospital discharge day management, more than 30 minutes | 25 | $2,428 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,407 | $83 |
| Short return visit (20+ min) | 17 | $1,059 | $62 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 139 | $20,134 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $14,230 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $12,591 | $180 |
| Hospital discharge day management, more than 30 minutes | 100 | $9,974 | $99 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $8,486 | $65 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,731 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $3,085 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,082 | $181 |
| Hospital observation care on day of discharge | 11 | $730 | $66 |
Medicaid work
$755,699 in 2024
Medicaid paid $755,699 for 18,544 billed services this clinician did in 2024, up to 201 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,362 | $697,764 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 96 | $43,555 |
| Short return visit (20+ min) | 1,271 | $3,493 |
| Return visit (30+ min) | 1,590 | $2,877 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 31 | $1,905 |
| Blood test, lipids (cholesterol and triglycerides) | 294 | $915 |
| Hemoglobin A1C level | 435 | $708 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 57 | $705 |
| Thyroid stimulating hormone (TSH) | 184 | $537 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 133 | $338 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 79 | $336 |
| HEPATITIS C ANTIBODY | 113 | $327 |
| 2024 | 18,544 | 52 | 201 | $755,699 |
| 2023 | 3,668 | 27 | 115 | $260,336 |
| 2022 | 7,985 | 31 | 170 | $639,806 |
| 2021 | 6,656 | 27 | 173 | $829,057 |
| 2020 | 2,186 | 9 | 149 | $247,040 |
| 2019 | 3,137 | 20 | 140 | $293,049 |
| 2018 | 416 | 4 | 22 | $11,653 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 508 | $253,854 |
| Return visit (30+ min) | 417 | $2,159 |
| Short return visit (20+ min) | 517 | $1,663 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 23 | $1,056 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 146 | $502 |
| Hemoglobin A1C level | 144 | $284 |
| Blood test, lipids (cholesterol and triglycerides) | 101 | $256 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 237 | $136 |
| Thyroid stimulating hormone (TSH) | 64 | $119 |
| HEPATITIS C ANTIBODY | 28 | $63 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 38 | $58 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 22 | $53 |
2022
| Clinic visit/encounter, all-inclusive | 1,294 | $623,952 |
| Short return visit (20+ min) | 1,776 | $5,529 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 112 | $2,772 |
| Return visit (30+ min) | 388 | $2,486 |
| Short return visit | 449 | $1,080 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 83 | $851 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 233 | $536 |
| Hemoglobin A1C level | 204 | $454 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 242 | $370 |
| Blood test, lipids (cholesterol and triglycerides) | 147 | $360 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 464 | $300 |
| HEPATITIS C ANTIBODY | 105 | $299 |
2021
| Clinic visit/encounter, all-inclusive | 1,744 | $821,406 |
| Short return visit (20+ min) | 1,967 | $3,517 |
| Short return visit | 819 | $1,318 |
| Return visit (30+ min) | 228 | $963 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 91 | $544 |
| PPSV23 VACC 2 YRS+ SUBQ/IM | 26 | $224 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 38 | $185 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 99 | $182 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 102 | $127 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 228 | $112 |
| Blood test, lipids (cholesterol and triglycerides) | 41 | $91 |
| ELECTROLYTE PANEL | 172 | $89 |
2020
| Clinic visit/encounter, all-inclusive | 751 | $244,370 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 177 | $1,224 |
| Short return visit (20+ min) | 878 | $1,091 |
| Short return visit | 300 | $277 |
| Blood test, lipids (cholesterol and triglycerides) | 12 | $31 |
| Thyroid stimulating hormone (TSH) | 12 | $26 |
| Hemoglobin A1C level | 12 | $15 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 14 | $6 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 30 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 900 | $287,688 |
| Short return visit (20+ min) | 1,321 | $2,410 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 74 | $1,406 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 25 | $657 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 95 | $418 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 69 | $131 |
| Blood test, lipids (cholesterol and triglycerides) | 52 | $70 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 133 | $67 |
| Thyroid stimulating hormone (TSH) | 30 | $64 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 77 | $52 |
| Hemoglobin A1C level | 57 | $44 |
| HEPATIC FUNCTION PANEL | 42 | $29 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 244 | $6,392 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 62 | $2,036 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 85 | $1,997 |
| 1ST HOSP IP/OBS HIGH 75 | 25 | $1,229 |
Drugs they prescribed that Part D paid
$447,492
Pharmacies billed $447,492 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (13 of 2,965) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
2,367 generic and 538 brand-name prescriptions · $447,492 in drug cost · 26 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 87 | $109,830 | $1,262 |
| Mounjaro | 42 | $49,826 | $1,186 |
| Rybelsus | 26 | $49,809 | $1,916 |
| Trulicity | 42 | $44,055 | $1,049 |
| Ozempic | 18 | $30,128 | $1,674 |
See all 60 drugs
| Jardiance | 87 | $109,830 | $1,262 |
| Mounjaro | 42 | $49,826 | $1,186 |
| Rybelsus | 26 | $49,809 | $1,916 |
| Trulicity | 42 | $44,055 | $1,049 |
| Ozempic | 18 | $30,128 | $1,674 |
| Eliquis | 33 | $29,397 | $891 |
| Xarelto | 16 | $11,997 | $750 |
| Basaglar Kwikpen U-100 | 15 | $5,896 | $393 |
| Advair Hfa | 12 | $4,426 | $369 |
| Fluticasone-Salmeterol | 15 | $3,666 | $244 |
| Vascepa | 13 | $3,610 | $278 |
| Ultra-Fine Nano Pen Needle | 30 | $2,241 | $75 |
| Atorvastatin | 294 | $1,934 | $7 |
| Gabapentin | 134 | $1,760 | $13 |
| Albuterol Sulfate Hfa | 44 | $1,644 | $37 |
| Ventolin Hfa | 27 | $1,454 | $54 |
| Bumetanide | 23 | $1,307 | $57 |
| Ultra-Fine Short Pen Needle | 12 | $1,126 | $94 |
| Clonidine | 11 | $949 | $86 |
| Tamsulosin | 68 | $647 | $10 |
| Omeprazole | 101 | $600 | $6 |
| Amlodipine Besylate | 179 | $556 | $3 |
| Metformin | 107 | $550 | $5 |
| Rosuvastatin | 13 | $486 | $37 |
| Potassium Chloride | 13 | $466 | $36 |
| Levothyroxine | 51 | $465 | $9 |
| Hydrocortisone | 33 | $423 | $13 |
| Losartan | 76 | $409 | $5 |
| Furosemide | 74 | $408 | $6 |
| Lisinopril | 89 | $390 | $4 |
| Benazepril | 43 | $388 | $9 |
| Fluticasone Propionate | 43 | $369 | $9 |
| Glipizide | 39 | $351 | $9 |
| Metoprolol | 26 | $324 | $12 |
| Bupropion Hcl Sr | 11 | $314 | $29 |
| Pantoprazole | 42 | $300 | $7 |
| Nifedipine Er | 15 | $281 | $19 |
| Fosinopril | 13 | $263 | $20 |
| Hydralazine | 29 | $262 | $9 |
| Ketoconazole | 19 | $243 | $13 |
| Chlorthalidone | 23 | $240 | $10 |
| Triamcinolone Acetonide | 44 | $236 | $5 |
| Carvedilol | 34 | $190 | $6 |
| Alendronate | 29 | $189 | $7 |
| Famotidine | 23 | $182 | $8 |
| Metformin Hcl Er | 24 | $177 | $7 |
| Baclofen | 36 | $162 | $5 |
| Simvastatin | 36 | $141 | $4 |
| Isosorbide Mononitrate Er | 15 | $139 | $9 |
| Atenolol | 20 | $132 | $7 |
| Clotrimazole | 16 | $119 | $7 |
| Metoprolol | 29 | $119 | $4 |
| Montelukast | 14 | $118 | $8 |
| Lactulose | 14 | $112 | $8 |
| Clopidogrel | 16 | $102 | $6 |
| Hydrochlorothiazide | 44 | $96 | $2 |
| Ondansetron | 20 | $93 | $5 |
| Trazodone | 28 | $73 | $3 |
| Fluoxetine | 13 | $62 | $5 |
| Cyclobenzaprine | 19 | $47 | $2 |
Year by year
| 2024 | 2,965 | 214 | 0% (13) | 18% | $447,492 |
| 2023 | 1,851 | 181 | None | 17% | $307,377 |
| 2022 | 2,719 | 263 | 1% (30) | 17% | $360,836 |
| 2021 | 1,167 | 240 | 2% (20) | 16% | $136,974 |
| 2020 | 747 | 139 | None | 18% | $77,094 |
| 2019 | 588 | 239 | None | None | $37,853 |
| 2018 | 179 | 76 | None | 17% | $10,034 |
| 2017 | 84 | 34 | None | 17% | $3,807 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 45 drugs
| Jardiance | 40 | $61,044 | $1,526 |
| Trulicity | 34 | $39,795 | $1,170 |
| Ozempic | 11 | $17,357 | $1,578 |
| Rybelsus | 15 | $17,327 | $1,155 |
| Novolog Flexpen | 11 | $10,993 | $999 |
| Advair Diskus | 12 | $10,493 | $874 |
| Atorvastatin | 187 | $5,501 | $29 |
| Bumetanide | 17 | $3,921 | $231 |
| Gabapentin | 73 | $3,265 | $45 |
| Potassium Chloride | 19 | $2,392 | $126 |
| Amlodipine Besylate | 121 | $2,328 | $19 |
| Ultra-Fine Nano Pen Needle | 13 | $1,884 | $145 |
| Isosorbide Dinitrate | 12 | $1,660 | $138 |
| Ventolin Hfa | 22 | $1,461 | $66 |
| Tamsulosin | 41 | $1,338 | $33 |
| Losartan | 48 | $1,320 | $27 |
| Omeprazole | 54 | $1,253 | $23 |
| Rosuvastatin | 15 | $1,243 | $83 |
| Glipizide | 42 | $1,109 | $26 |
| Metformin | 89 | $1,031 | $12 |
| Pantoprazole | 44 | $975 | $22 |
| Simvastatin | 34 | $878 | $26 |
| Albuterol Sulfate Hfa | 21 | $817 | $39 |
| Bupropion Hcl Sr | 14 | $713 | $51 |
| Levothyroxine | 39 | $691 | $18 |
| Fluticasone Propionate | 28 | $666 | $24 |
| Benazepril | 23 | $659 | $29 |
| Lisinopril | 40 | $643 | $16 |
| Oxybutynin Chloride | 14 | $631 | $45 |
| Atenolol | 26 | $627 | $24 |
| Metformin Hcl Er | 17 | $569 | $33 |
| Famotidine | 20 | $525 | $26 |
| Hydralazine | 19 | $473 | $25 |
| Carvedilol | 19 | $453 | $24 |
| Metoprolol | 20 | $452 | $23 |
| Alendronate | 17 | $408 | $24 |
| Metoprolol | 24 | $380 | $16 |
| Furosemide | 32 | $379 | $12 |
| Clopidogrel | 14 | $337 | $24 |
| Fosinopril | 15 | $319 | $21 |
| Hydrochlorothiazide | 34 | $241 | $7 |
| Diclofenac | 12 | $218 | $18 |
| Triamcinolone Acetonide | 18 | $187 | $10 |
| Trazodone | 14 | $161 | $11 |
| Sertraline | 14 | $122 | $9 |
2022: 62 drugs
| Jardiance | 53 | $70,421 | $1,329 |
| Trulicity | 17 | $28,456 | $1,674 |
| Januvia | 12 | $20,179 | $1,682 |
| Rybelsus | 14 | $19,153 | $1,368 |
| Advair Diskus | 29 | $19,067 | $657 |
| Eliquis | 26 | $15,124 | $582 |
| Flovent Hfa | 21 | $7,468 | $356 |
| Basaglar Kwikpen U-100 | 13 | $5,852 | $450 |
| Isosorbide Dinitrate | 12 | $4,971 | $414 |
| Bumetanide | 14 | $4,568 | $326 |
| Atorvastatin | 226 | $3,863 | $17 |
| Gabapentin | 119 | $2,837 | $24 |
| Albuterol Sulfate Hfa | 44 | $2,082 | $47 |
| Duloxetine | 11 | $1,833 | $167 |
| Potassium Chloride | 25 | $1,683 | $67 |
| Rosuvastatin | 18 | $1,491 | $83 |
| Amlodipine Besylate | 168 | $1,345 | $8 |
| Ventolin Hfa | 23 | $1,287 | $56 |
| Levothyroxine | 51 | $1,270 | $25 |
| Omeprazole | 58 | $1,221 | $21 |
| Metformin | 108 | $1,121 | $10 |
| Losartan | 77 | $1,071 | $14 |
| Tamsulosin | 43 | $1,013 | $24 |
| Ultra-Fine Nano Pen Needle | 11 | $839 | $76 |
| Montelukast | 28 | $770 | $28 |
| Baclofen | 20 | $744 | $37 |
| Metoprolol | 32 | $712 | $22 |
| Benazepril | 37 | $642 | $17 |
| Bupropion Hcl Sr | 14 | $601 | $43 |
| Pantoprazole | 52 | $579 | $11 |
| Glipizide | 60 | $578 | $10 |
| Lisinopril | 59 | $544 | $9 |
| Triamcinolone Acetonide | 40 | $535 | $13 |
| Hydralazine | 26 | $500 | $19 |
| Simvastatin | 44 | $495 | $11 |
| Fluticasone Propionate | 41 | $493 | $12 |
| Furosemide | 55 | $477 | $9 |
| Carvedilol | 34 | $476 | $14 |
| Famotidine | 36 | $452 | $13 |
| Cyclobenzaprine | 17 | $447 | $26 |
| Alendronate | 28 | $405 | $14 |
| Fosinopril | 22 | $388 | $18 |
| Amitriptyline | 11 | $378 | $34 |
| Metformin Hcl Er | 22 | $357 | $16 |
| Atenolol | 35 | $341 | $10 |
| Metoprolol | 26 | $338 | $13 |
| Oxybutynin Chloride | 13 | $328 | $25 |
| Clopidogrel | 23 | $312 | $14 |
| Diclofenac | 15 | $277 | $18 |
| Sucralfate | 11 | $271 | $25 |
| Hydrochlorothiazide | 47 | $269 | $6 |
| Lactulose | 17 | $174 | $10 |
| Isosorbide Mononitrate Er | 14 | $170 | $12 |
| Hydrocortisone | 13 | $166 | $13 |
| Mupirocin | 13 | $159 | $12 |
| Venlafaxine Hcl Er | 13 | $139 | $11 |
| Sertraline | 18 | $125 | $7 |
| Ibuprofen | 22 | $109 | $5 |
| Hydroxyzine | 16 | $99 | $6 |
| Trazodone | 17 | $94 | $6 |
| Tramadol | 19 | $74 | $4 |
| Fluoxetine | 12 | $29 | $2 |
2021: 26 drugs
| Trulicity | 13 | $14,844 | $1,142 |
| Gabapentin | 81 | $1,095 | $14 |
| Atorvastatin | 81 | $1,075 | $13 |
| Albuterol Sulfate Hfa | 22 | $1,002 | $46 |
| Ultra-Fine Nano Pen Needle | 12 | $838 | $70 |
| Levothyroxine | 23 | $436 | $19 |
| Baclofen | 23 | $417 | $18 |
| Losartan | 33 | $381 | $12 |
| Amlodipine Besylate | 62 | $358 | $6 |
| Omeprazole | 27 | $337 | $12 |
| Metformin | 36 | $284 | $8 |
| Glipizide | 24 | $268 | $11 |
| Pantoprazole | 24 | $208 | $9 |
| Carvedilol | 17 | $206 | $12 |
| Furosemide | 28 | $206 | $7 |
| Metoprolol | 11 | $200 | $18 |
| Fluticasone Propionate | 14 | $171 | $12 |
| Famotidine | 18 | $169 | $9 |
| Lisinopril | 18 | $131 | $7 |
| Simvastatin | 17 | $122 | $7 |
| Benazepril | 15 | $121 | $8 |
| Triamcinolone Acetonide | 18 | $111 | $6 |
| Tamsulosin | 12 | $105 | $9 |
| Metoprolol | 17 | $78 | $5 |
| Hydrochlorothiazide | 18 | $72 | $4 |
| Sertraline | 13 | $57 | $4 |
2020: 19 drugs
| Tradjenta | 15 | $13,615 | $908 |
| Lantus | 19 | $6,415 | $338 |
| Atorvastatin | 61 | $806 | $13 |
| Ventolin Hfa | 14 | $802 | $57 |
| Gabapentin | 34 | $360 | $11 |
| Famotidine | 21 | $286 | $14 |
| Glipizide | 33 | $262 | $8 |
| Amlodipine Besylate | 48 | $256 | $5 |
| Fluticasone Propionate | 15 | $156 | $10 |
| Losartan | 21 | $152 | $7 |
| Metformin | 25 | $147 | $6 |
| Lisinopril | 20 | $103 | $5 |
| Baclofen | 14 | $101 | $7 |
| Omeprazole | 11 | $85 | $8 |
| Hydrocortisone | 13 | $82 | $6 |
| Alendronate | 12 | $81 | $7 |
| Simvastatin | 16 | $62 | $4 |
| Carvedilol | 13 | $54 | $4 |
| Ibuprofen | 12 | $29 | $2 |
2019: 8 drugs
| Ventolin Hfa | 23 | $1,288 | $56 |
| Gabapentin | 35 | $305 | $9 |
| Atorvastatin | 19 | $269 | $14 |
| Baclofen | 13 | $248 | $19 |
| Amlodipine Besylate | 35 | $202 | $6 |
| Triamcinolone Acetonide | 15 | $103 | $7 |
| Fluticasone Propionate | 13 | $93 | $7 |
| Furosemide | 16 | $56 | $3 |
2018: 4 drugs
| Atorvastatin | 11 | $88 | $8 |
| Levofloxacin | 12 | $71 | $6 |
| Prednisone | 11 | $55 | $5 |
| Amlodipine Besylate | 12 | $51 | $4 |
Money from drug and device companies
$196 in 2025
| 2025 | 1 | 4 | None | $196 |
| 2022 | 1 | 2 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sun Pharmaceutical Industries | Cequa | $196 | 4 payments
|
See all 4 published payments
| Sun Pharmaceutical Industries | Meals · 2025-08-21 | Cequa | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-08-21 | Cequa | $125 |
| Sun Pharmaceutical Industries | Meals · 2025-05-20 | Cequa | $33 |
| Sun Pharmaceutical Industries | Meals · 2025-05-07 | Cequa | $20 |
See earlier years (2022)
2022: $41
| Boston Scientific | Rotapro | $41 | 2 payments
|
Professional record
- NPI
- 1619396512
- Licence
- CA 20A14473
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 225 N Jackson Ave, San Jose, CA, 95116
- NPI first listed
- 2014-04-08
- NPI last updated
- 2023-11-01
- NPI record certified
- 2023-11-01
This is when the NPI record was last certified, not a medical board exam.